Pharmacie KOHL-ZONDERMAN
0421.088.084 · rovalta.com · 26/09/2026
Pharmacie KOHL-ZONDERMAN
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPharmacie KOHL-ZONDERMAN is a Private limited company incorporated in 1980. Its registered office is in Ans. It employs on average 1,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0421.088.084
- Incorporation
- 01/10/1980
- Legal form
- Private limited company
- Registered office
- Rue Commandant Naessens 68
4431 Ans · WallonieSee on map - Contributed capital
- 19 050,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,4 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 172,3 k € | -1.6% | 175,1 k € | +14.1% | 153,5 k € | -13.7% | 177,9 k € | -13.5% | 205,7 k € |
| EBITDA | 52,5 k € | -25.4% | 70,4 k € | +70.8% | 41,2 k € | -20.7% | 51,9 k € | -41.6% | 89 k € |
| Operating result | 28,9 k € | -38.7% | 47,1 k € | +137% | 19,9 k € | -36.1% | 31,1 k € | -58.7% | 75,3 k € |
| Net result | 21 k € | -42.1% | 36,3 k € | +119% | 16,5 k € | -33.4% | 24,9 k € | -61.9% | 65,2 k € |
| Balance sheet | |||||||||
| Equity | 342,8 k € | +0.3% | 341,8 k € | +0.1% | 341,6 k € | +0.0% | 341,5 k € | +1.4% | 336,7 k € |
| Total assets | 453,6 k € | -1.9% | 462,5 k € | +3.9% | 445,2 k € | -2.2% | 455,1 k € | -20.9% | 575,6 k € |
| Cash | 128,8 k € | +5.4% | 122,2 k € | +6.5% | 114,7 k € | +6.4% | 107,9 k € | -12.5% | 123,2 k € |
| Debts | 105,4 k € | -8.5% | 115,1 k € | +16.9% | 98,5 k € | -8.9% | 108,2 k € | -53.7% | 233,5 k € |
| Other | |||||||||
| Workforce | 1,4 ETP | -26.3% | 1,9 ETP | -13.6% | 2,2 ETP | +4.8% | 2,1 ETP | 0.0% | 2,1 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Rue Commandant Naessens 68 4431 Ans| Company | CBE no. |
|---|---|
MIVAPHARM● Active | 0473.651.691 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/07/2026 | 18/07/2025 | 12/08/2024 | 31/08/2023 | 28/07/2022 | 20/08/2021 |
| General meeting | 12/06/2026 | 20/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 12/06/2026 | 10/07/2026 | French | |
| Abridged model | 31/12/2024 | 20/06/2025 | 18/07/2025 | French | |
| Abridged model | 31/12/2023 | 30/06/2024 | 12/08/2024 | French | |
| Abridged model | 31/12/2022 | 30/06/2023 | 31/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/06/2022 | 28/07/2022 | French | |
| Abridged model | 31/12/2020 | 30/06/2021 | 20/08/2021 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 10/08/2020 | French | |
| Abridged model | 31/12/2018 | 30/06/2019 | 29/07/2019 | French | |
| Abridged model | 31/12/2017 | 30/06/2018 | 30/07/2018 | French | |
| Abridged model | 31/12/2016 | 29/06/2017 | 06/07/2017 | French | |
| Abridged model | 31/12/2015 | 29/07/2016 | 05/08/2016 | French | |
| Abridged model | 31/12/2014 | 10/07/2015 | 30/07/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 29/07/2014 | French | |
| Abridged model | 31/12/2012 | 20/06/2013 | 12/07/2013 | French | |
| Abridged model | 31/12/2011 | 21/06/2012 | 12/07/2012 | French | |
| Abridged model | 31/12/2010 | 03/06/2011 | 15/06/2011 | French | |
| Abridged model | 31/12/2009 | 17/06/2010 | 05/07/2010 | French | |
| Abridged model | 31/12/2008 | 24/06/2009 | 02/07/2009 | French | |
| Abridged model | 31/12/2007 | 30/06/2008 | 22/07/2008 | French | |
| Abridged model | 31/12/2006 | 20/06/2007 | 09/07/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Publications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202521 k €↓
- 2024Annual accounts 202436,3 k €↑
- 2023Annual accounts 202316,5 k €↓
- 2022Annual accounts 202224,9 k €↓
- 2021Annual accounts 202165,2 k €↑
- 2020Annual accounts 202038,3 k €↓
- 2019Annual accounts 201938,6 k €↑
- 2018Annual accounts 201829,3 k €↑
- 2017Annual accounts 20175 k €↓
- 2016Annual accounts 201620,2 k €↓
- 2015Annual accounts 201537,8 k €↓
- 2014Annual accounts 201439 k €↑
- 2013Annual accounts 201325,5 k €↑
- 2012Annual accounts 201216,7 k €↓
- 2011Annual accounts 201121,6 k €↓
- 2010Annual accounts 201029,3 k €↓
- 2009Annual accounts 200930,8 k €↓
- 2008Annual accounts 200833,5 k €↓
- 2007Annual accounts 200737,2 k €↑
- 2006Annual accounts 200630,9 k €
- 01/10/1980IncorporationPrivate limited company